Watermark
  Back to Search Results

BGB-A317-305

Completed

Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-305

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03777657

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2018

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20181841

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan Plain Language Summary

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan Plain Language Summary